|Publication number||US20120037161 A1|
|Application number||US 13/280,687|
|Publication date||Feb 16, 2012|
|Filing date||Oct 25, 2011|
|Priority date||Feb 21, 2003|
|Also published as||CN1750853A, CN100566771C, EP1603617A1, EP1603617A4, US8042538, US20040221850, WO2004073777A1, WO2004073777A8|
|Publication number||13280687, 280687, US 2012/0037161 A1, US 2012/037161 A1, US 20120037161 A1, US 20120037161A1, US 2012037161 A1, US 2012037161A1, US-A1-20120037161, US-A1-2012037161, US2012/0037161A1, US2012/037161A1, US20120037161 A1, US20120037161A1, US2012037161 A1, US2012037161A1|
|Inventors||Anthony M. Ging, Philip R. Kwok, Gary C. Robinson, Bianto Santoso, Rachael E. Moore, Partick J. McAuliffe|
|Original Assignee||Resmed Limited|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (6), Referenced by (4), Classifications (11), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation of U.S. Ser. No. 10/781,949, filed Feb. 20, 2004, which claims the benefit of U.S. Provisional Patent Application Nos. 60/448,533 filed Feb. 21, 2003 and 60/465,790 filed Apr. 28, 2003, each of which is incorporated herein by reference in its entirety.
1. Field of the Invention
The invention relates to a nasal mask assembly for use with non-invasive positive pressure ventilation (NIPPV) applied to small adults or pre-adults with sleep disordered breathing (SDB).
2. Description of Related Art
Sleep-disordered breathing is a general term for a sleep disorder with apneas and hypopneas. Apneas are generally taken to be a cessation of airflow for ten seconds or longer. Hypopnea are generally taken to be a 50% or greater decrease in air flow for ten seconds or longer. Both apneas and hypopneas cause sleep arousals—moments when an individual wakes enough to resume breathing but not enough to remember any interruption of sleep. Some arousals simply cause the sleeper to shift into a lighter stage of sleep. In either case, the arousal lessens the quality of sleep. Apneas and hypopneas may cause blood oxygen levels to drop. Apneas and hypopneas result from upper airway obstruction, either full or partial, or a dysfunction of the body's automatic drive to breathe.
Obstructive Sleep Apnea (OSA) is a common disorder. Estimates for the number of Americans with OSA vary depending on the criteria researchers use for the study. Conservative estimates, however, put the number of adult Americans with OSA at approximately 20 million. OSA occurs because of upper airway obstructions that can cause you to snore or to stop breathing. Obstructions occur during sleep for two primary reasons: lack of muscle tone and/or gravity. Excess tissue in the upper airway and anatomic abnormalities compound these factors. During sleep, especially in REM sleep, our bodies relax, and muscle tissues like the tongue and soft palate lose their slight rigidity. Because we tend to sleep lying down, gravity pulls these tissues toward the back of the throat and closes the upper airway.
The use of nasal Continuous Positive Airway Pressure (nasal CPAP) to treat obstructive sleep apnea (OSA) was taught by Sullivan in U.S. Pat. No. 4,944,310. Today apparatus for OSA typically comprises (i) a blower which provides a supply of air or breathable gas at positive pressure, (ii) an air delivery conduit connected to the blower, and (iii) a patient interface, such as a nasal mask, which is connected to the air delivery conduit.
A variety of nasal masks have been developed. One such mask is the MIRAGE® mask, manufactured by ResMed Limited and described in U.S. Pat. Nos. 6,112,746; 6,357,441; 6,119,693 and 6,463,931, amongst others. Another such mask is the ULTRA MIRAGE® mask, also manufactured by ResMed Limited. The ULTRA MIRAGE® mask is described in U.S. Pat. Nos. 6,112,746, 6,357,441, 6,374,826, 6,412,487, 6,439,230 and 6,463,931.
The American Academy of Pediatrics, in a Technical Report on the Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome (OSAS) (PEDIATRICS Vol. 109 No. 4 April 2002) noted that “Snoring is a common occurrence in childhood, with reported prevalence between 3.2% and 12.1%. The prevalence of childhood OSAS is difficult to estimate, largely because published studies use different PSG criteria for its ascertainment. Reports range from 0.7% to 10.3%.”
A key factor in the efficacy of therapy and compliance of patients with therapy is the comfort and fit of masks. Whilst there are a large number of masks designed for adults, there are relatively few designed to suit children.
One mask designed for children is the SULLIVAN® Nasal CPAP system, Infant Nasal Bubble Mask System with Sensor tubing, manufactured by ResMed Limited. See
Other infant masks are shown in the following patents: FR 2775905; GB 2277688; US 2002/0104531; U.S. Pat. No. 3,827,433; U.S. Pat. No. 4,232,476; U.S. Pat. No. 4,406,283; U.S. Pat. No. 4,774,946; U.S. Pat. No. 4,896,666; U.S. Pat. No. 4,832,015; U.S. Pat. No. 5,271,391; U.S. Pat. No. 5,318,590; U.S. Pat. No. 5,462,050; U.S. Pat. No. 5,509,408; U.S. Pat. No. 5,535,741; U.S. Pat. No. 5,813,423; U.S. Pat. No. 5,660,174; U.S. Pat. No. 6,418,929; WO 01/32250 ;WO 02/05883 ;WO 95/09023
One adult mask is the VISTA™ mask, manufactured by ResMed Limited, and described in Australian Provisional Patent Application PS1926, filed 23 April 2002; U.S. 60/377,254 filed 3 May 2002; U.S. 60/397,195 filed 22 Jul. 2002; U.S. 60/402,509 filed 12 Aug. 2002; and U.S. Ser. Nos. 10/391,440, 10/390,682, 10/390,681, 10/390,720 and 10/390,826, all filed 19 Mar. 2003, the contents of which are hereby incorporated by cross-reference. An ornamental design applied to the VISTA™ mask is shown in design patent application U.S. Des Pat. No. 29/166,190, the contents of which are hereby incorporated by reference.
The VISTA™ mask includes a cushion, a frame, an elbow and headgear including a yoke.
While the VISTA™ mask is particularly suitable for adults, the problem arises as to how such an adult mask can be adapted to suit children.
International Patent Application WO2001/32250 (Sullivan & Wilkie) describes a mask for supplying gas under pressure to the nasal airway of an infant human. In that application, the following is stated:
In accordance with a first aspect of the invention a mask assembly suitable for pre-adults is provided.
In accordance with a second aspect of the invention a system of cushions, frames, headgear, yokes and other mask components are provided which fit a wide range of pre-adults with a good seal and which are economic to bring to market.
In accordance with another aspect of the invention, a system of mask cushions is provided for pre-adults in which the cushion for children aged generally 2-6 years has a shallower nasal bridge region than the cushion for pre-adults aged generally 6-16 years.
In accordance with another aspect of the invention, a system of mask cushions is provided for pre-adults in which the cushion for children aged generally 2-6 years has larger radius lower corner edges of the membrane than the cushion for pre-adults aged generally 6-16 years.
In accordance with another aspect of the invention, a system of mask cushions is provided for pre-adults aged generally 6-16 years which are adapted to be mounted to corresponding adult sized frames.
In one preferred embodiment, headgear for use with a respiratory mask includes first and second straps each adapted to be provided to a mask frame of the mask, where each of the first and second straps includes a yoke, each said yoke being constructed and arranged to accommodate at least one of a pre-adult patient or a small sized adult patient.
In another embodiment, which can be used with the headgear described above, a cushion for use with a nasal mask includes an outer membrane including a face-contact portion to form a seal with the patient; and an underlying rim positioned below the membrane, wherein the membrane and the rim are formed and positioned with respect to one another to accommodate at least one of a pre-adult patient or a small sized adult patient.
These and other aspects will be described in or apparent from the following description.
Preferred embodiments will be described in relation to the following drawings, in which:
Stabilization of the cushion 110 and frame 120 on the face 220 of an adult patient 200 is assisted by the size, shape and positioning of the yoke 170 on the headgear 150. In spite of the problems identified by Sullivan & Wilkie concerning the fulcrum and torsional effects of prior art masks, greater stability can be achieved in pre-adults with a mask in accordance with the present invention. In one embodiment, the present inventors have redesigned the VISTA™ mask in
The US Food & Drug Administration (FDA) makes the following classifications for pre-adults:
1 month-2 years
2 years to 12 years
12 years to 16 years
In accordance with an aspect of the invention, a mask system is provided which uses a different classification:
The mask system can fit the same range of pre-adults defined by the FDA, however, four separate mask systems are not required.
In adults, a system of masks suitable for fitting a range of people should take into account body mass and racial nose characteristics. For example, the East Asian-shaped nose typically has a lower nasal bridge region compared to the Caucasian-shaped nose. However, below the ages of 5-7 there are few racial distinctions in children. In particular, neo-nates, infants and young children have no nasal bridge. Not only do children have smaller heads and faces than adults, their heads and faces are differently shaped. In accordance with an aspect of the invention, a system of mask & headgear sizes has been developed in which a minimal set of components can be used to fit the widest range of people:
An advantage with the mask system described herein is that a very wide range of pre-adults can find a mask which fits well with little leak, is comfortable, and yet is economic for manufacturers to produce and bring to market. Since the pediatric, small adult, or pre-adult market is relatively small in comparison to the standard adult market, there is a reduced economic incentive for business to bring product to the market. However, when a system in accordance with the invention is produced, it becomes more economically viable to produce such masks.
Table 4 compares dimensions of related art VISTA™ headgear yoke with two “small” headgear yokes, referred to as the “Mini” and “Kid,” in accordance with preferred embodiments of the invention. The first row of Table 4 identifies four features (A, B, C and D) of the headgear yoke. These features are shown in
VISTA ™ (related art)
embodiment - “Mini”
embodiment - “Kid”
embodiment - “Kidsta-S”
The headgear strap 162 may include the dimensions as shown in
The cushion 110 is constructed from a silicone material, such as that used for the VISTA™ mask, although other materials could be used, e.g., gel, foam, silicone and combinations thereof.
In accordance with an embodiment of the invention, 2-3 “Kid” cushion sizes and 2-3 “Mini” cushion sizes can be used to fit pre-adults from 2 to 16 years.
Since the “Kid” range of cushions fit adult VISTA™ frames, e.g., see frame 120 in
Moreover, the smaller area covered by the Kidsta Small and Kidsta Extra Small masks results in reduced headgear loading. The smaller area of face exposed to the air pressure in the mask results in a smaller overall reaction force, as force is equal to pressure by area. The reaction force from the pressure in the mask is a significant component of the load on the mask, especially at higher air pressures. Hence the total load on the mask, and the headgear strap loads required to match this load, will be less with the small mask area.
Both the “Kid” and “Mini” range of cushions are not only smaller than adult range of VISTA™ cushions, they have a different shape. For example, both the “Kid” and “Mini” cushions have relatively shallower notches in the nasal bridge region and relatively shallower curves in the lip region compared to an adult VISTA™ cushion. See also
Table 5 shows the change in size of a “Kid” cushion in accordance with one embodiment of the invention. The membrane 910 of the cushion 110 has an orifice 975 (
As compared to the VISTA™ cushion, the orifice 985 of the rim 920 is about 3 mm smaller all around its perimeter, however the membrane 910 is smaller by an amount varying from about 0 to 3 mm.
“Kid” v. VISTA ™ - Cushion Comparison
0 mm in nasal
−3 mm in all regions
−2 mm in lip region
−3 mm in side region
Height of patient
+6 mm in nasal
+3 mm in nasal
+3 mm in lip region
+3 mm in lip region
+2 mm in side region
+1 mm in side region
Kid Orifice span
nasal bridge region - 23
nasal bridge region - 35
lip region - 31
lip region - 33
side region - 19
side region - 43
Kid Height of
nasal bridge region - 28
nasal bridge region - 14
lip region - 20.7
lip region - 16
ing region from
side region - 34
side region - 26
In accordance with another embodiment of the invention, a “Kid” cushion has a further 3-4 mm increase in height of the membrane in the patient contacting-portion from the frame-engaging portion in the nasal bridge region, hence a total of 9-10 mm when compared to an adult cushion. There is a corresponding change in the rim.
In accordance with another embodiment of the invention, a “Mini” cushion has a further 6-7 mm increase in height of the membrane in the patient contacting-portion from the frame-engaging portion in the nasal bridge region, hence a total of 12-13 mm when compared to an adult cushion. There is a corresponding change in the rim. In this way, a “Mini” cushion has an even shallower notch in the nasal bridge region compared to a “Kid” cushion. Since a “Mini” cushion uses a smaller frame than a “Kid” cushion, it does not have the generally sloping outer wall in the transition region between the face-contacting portion and the frame-engaging portion. Furthermore, the “Mini” cushion is generally closer to the face for better stability. Such a shallower notch is indicated by broken line 990 in
In general the materials used to construct a mask assembly in accordance with the invention are the same as those used to construct the VISTA™ mask.
As shown in
Further cushion embodiments of the invention are described in relation to
The underlying rim 920 should preferably have the same cross section as the VISTA™, e.g., where it attaches to the frame as shown in
As to the underlying rim 920, one aspect is to reduce the size of the opening 985 substantially along an entire extent thereof so that the width and effective height dimensions correspond to Table 6, all dimensions being in mm. For example, the width of the Kidsta S and XS may be in the range of about 30-42 mm, the effective height may be in the range of about 32-42 mm, and the effective bridge depth may be about 13-24 mm, although other dimensions are also possible. See
VISTA ™, Kidsta S + Kidsta XS - Cushion
KIDSTA - S
The top lip 950 area should be raised so that a distance z is about 2 mm. See
The “Kid” or “Mini” can also be better dimensioned and/or shaped to avoid leak at the nasal bridge region, especially for kids under age 11 years old, to avoid intrusion into the eyes, to avoid discomfort stemming from a “hard-edged” cushion, and/or to reduce the size of the cushion, e.g., to avoid dead air space.
To better avoid intrusion into the eyes, the Kidsta XS cushion can be further shortened (compared to the Kidsta S) by about 5 mm to avoid the eye sockets. As mentioned, the frame size preferably remains the same.
The Kid or Mini cushion depth was about 3 mm deeper than the VISTA™, which may introduce possible instability and make headgear difficult to fit. In the Kidsta S, the height is reduced approximately to the height of the VISTA™.
In the Kid or Mini, the radius was smaller across the top lip (compared to the VISTA™) with no leaks or discomfort reported. Thus for the Kidsta S according to the present embodiment, maintain the 2 mm smaller radius compared to the VISTA™. For the Kidsta XS, the radius should be further reduced another 2 mm, in proportion, which may help accommodate patients with smaller lips. See
As for sizing strategy, one aim is to use only 2 sizes with roughly equal population coverage. The dimensions which have the most impact on sizing are the maximum nose width (limits mask width), the minimum nose height from septum to eye line (limits mask height) and the minimum nasal bridge depth (limits shallowness of the mask). The inventors have found that width and height growth is approximately linear for the 5-16 age group. The masks are designed to fix approximately 5 year age blocks, and to fit the largest width and smallest height within each block. The data from the middle of the nasal bridge region is not widely available, so it is also assumed to be linear within each block. See Table 7, below.
VISTA ™ Standard
Kid or Mini
Kidsta Extra Small
As shown in
The headgear clip 140 as shown in the VISTA™ (
The existing VISTA™ type frame 120 includes cheek pieces (see
A problem may arise because different people have different face widths. A frame width that provides optimal contact for one person will be too tight for another person and too loose for a third.
If the frame is too tight, the patient may suffer from pain or skin damage, or will adjust the mask so that it is no longer too tight, but it will no longer seal or provide effective treatment. If the mask is too loose, the mask will have excessive side to side movement, especially when the patient turns to the side and presses one cheek into the pillow.
Another aspect of the invention is to chose a size that suits the largest number of patients, with a bias towards being too loose in preference to being too tight. It is envisaged that a range of sizes may be introduced so that customers may choose from a narrow, medium or wide mask frame.
There are a number of different ways that this idea can be implemented. For example, the cheek pieces 123 can be mounted on a hinge so that they can swing in or out. The cheek pieces 123 may be either free to move or they could be locked into one or more predetermined positions, via detents, friction, and/or a pin and slot arrangement.
Alternatively, the cheek pieces 123 can be flexibly mounted, so that they can bend in or out without requiring much force. If they are set so that the neutral position is wider than the patient's face, the tension in the headgear will pull the cheek pieces in towards the ideal position for that person.
In a further alternative, if the cheek pieces 123 are set so that the neutral position is narrower than the patient's face, the cheeks will push the cheek pieces out towards the ideal position for that person. In another method, the cheek pieces could be adjusted in or out using some sort of adjustment mechanism, such as a screw adjustment.
With movable cheek pieces, the mask can be more comfortable for a wider range of patients. Those patients with wide faces would no longer suffer from excessive pressure on the cheeks.
It would also be more securely mounted on the face, resulting in less mask movement for those with thin faces, or for people with wide faces who may adjust the mask poorly in an attempt to make it more comfortable. This greater security will result in less leakage, leading to greater comfort and more effective treatment.
This will make the VISTA™ type mask easier to fit onto a variety of different face shapes. Because one mask will fit such a large range, less inventory will be required.
Use of an adjustable mask frame will stop the need for having more than one frame size. This will reduce inventory and tooling costs.
The ease of fitting a wide variety of facial shapes will increase the range of people to whom the masks will be attractive. Although the invention has been described with reference to particular embodiments, it is to be understood that this embodiment is merely illustrative of the application of the principles of the invention. Numerous modifications may be made therein and other arrangements may be devised without departing from the spirit and scope of the invention.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4907584 *||Mar 3, 1988||Mar 13, 1990||Mcginnis Gerald E||Respiratory mask|
|US5746201 *||Jan 23, 1997||May 5, 1998||Nellcor Puritan-Bennett||CPAP nose mask|
|US6397847 *||Sep 1, 1999||Jun 4, 2002||Respironics, Inc.||Customizable seal, mask with customizable seal and method of using such a seal|
|US6907882 *||Mar 19, 2003||Jun 21, 2005||Resmed Limited||Ergonomic and adjustable respiratory mask assembly with headgear assembly|
|US20030019495 *||May 16, 2002||Jan 30, 2003||Palkon David J.||Mask cushion and method of using same|
|US20060118117 *||Nov 6, 2003||Jun 8, 2006||Michael Berthon-Jones||Mask and components thereof|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|USD690003||Nov 8, 2012||Sep 17, 2013||Resmed Limited||Yoked headgear|
|USD719254||Sep 16, 2013||Dec 9, 2014||Resmed Limited||Elbow connector for respiratory mask|
|USD736908||Sep 16, 2013||Aug 18, 2015||Resmed Limited||Headgear-to-frame connection component for respiratory mask|
|WO2013182952A1 *||May 28, 2013||Dec 12, 2013||Koninklijke Philips N.V.||Pediatric total facemask cross-reference to related applications;|
|U.S. Classification||128/206.24, 128/206.21|
|International Classification||A61M16/06, A61M16/00|
|Cooperative Classification||A61M2210/0618, A61M16/06, A61M16/0683, A61M16/0616, A61M16/0622|
|European Classification||A61M16/06, A61M16/06S|
|Aug 5, 2013||AS||Assignment|
Owner name: RESMED LIMITED, AUSTRALIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GING, ANTHONY MICHAEL;KWOK, PHILIP RODNEY;ROBINSON, GARYCHRISTOPHER;AND OTHERS;SIGNING DATES FROM 20040520 TO 20040615;REEL/FRAME:030955/0359
Effective date: 20040618
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SANTOSO, BIANTO;REEL/FRAME:030955/0509
Owner name: RESMED LIMITED, AUSTRALIA